Nome | Settore | Analyst Name | Analyst Job Title | Rating Quantitativo | Data | |
---|---|---|---|---|---|---|
Shanghai Pharmaceuticals Holding Co Ltd Class H | Salute | Yurou Zheng | Equity Analyst | 30/04/2025 | ||
Incyte Corp | Salute | Rachel Elfman | Equity Analyst | 29/04/2025 | ||
Labcorp Holdings Inc | Salute | Debbie Wang | Senior Equity Analyst | 29/04/2025 | ||
Guangzhou Kingmed Diagnostics Group Co Ltd Class A | Salute | Yurou Zheng | Equity Analyst | 29/04/2025 | ||
Medpace Holdings Inc | Salute | Rachel Elfman | Equity Analyst | 29/04/2025 | ||
Daiichi Sankyo Co Ltd | Salute | Jay Lee | Senior Equity Analyst | 29/04/2025 | ||
Siegfried Holding AG | Salute | Rachel Elfman | Equity Analyst | 28/04/2025 | ||
Tilray Brands Inc | Salute | Kristoffer Inton | Strategist | 28/04/2025 | ||
Revvity Inc | Salute | Julie Utterback | Senior Equity Analyst | 28/04/2025 | ||
Telix Pharmaceuticals Ltd Ordinary Shares | Salute | Shane Ponraj | Equity Analyst | 28/04/2025 | ||
Chugai Pharmaceutical Co Ltd | Salute | Jay Lee | Senior Equity Analyst | 25/04/2025 | ||
Gilead Sciences Inc | Salute | Karen Andersen | Director | 25/04/2025 | ||
West Pharmaceutical Services Inc | Salute | Jay Lee | Senior Equity Analyst | 24/04/2025 | ||
Galderma Group AG Registered Shares | Salute | Diana Radu | Equity Analyst | 24/04/2025 | ||
ResMed Inc | Salute | Shane Ponraj | Equity Analyst | 24/04/2025 | ||
ResMed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh | Salute | Shane Ponraj | Equity Analyst | 24/04/2025 | ||
Edwards Lifesciences Corp | Salute | Debbie Wang | Senior Equity Analyst | 24/04/2025 | ||
Thermo Fisher Scientific Inc | Salute | Alex Morozov | Regional Director | 23/04/2025 | ||
Boston Scientific Corp | Salute | Debbie Wang | Senior Equity Analyst | 23/04/2025 | ||
Eurofins Scientific SE | Salute | Max Jousma | Equity Analyst | 23/04/2025 |